Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer

PURPOSE: Irinotecan is effective for metastatic colorectal cancer (mCRC). SN-38 is an active metabolite of irinotecan, which is formed by carboxylesterase and inactivated by UDP-glucuronyltransferase (UGT) 1A1. The UGT enzyme activity is reduced in patients with homozygous mutation in UGT1A1 genes (...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Hironori, Yamada, Yunami, Watanabe, Daichi, Matsuhashi, Nobuhisa, Takahashi, Takao, Yoshida, Kazuhiro, Suzuki, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373181/
https://www.ncbi.nlm.nih.gov/pubmed/30377777
http://dx.doi.org/10.1007/s00280-018-3711-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373181/
https://www.ncbi.nlm.nih.gov/pubmed/30377777
http://dx.doi.org/10.1007/s00280-018-3711-8

Ejemplares similares